Interview with Pharma Equity Group’s CEO Thomas Kaas Selsø
Analys
2024-11-15
Irisity
Kommentar
Comment on PEG’s Q3 Report for 2024
Comment on Björn Borgs Q3 Report for 2024
2024-11-14
Kommentar på CirChems Q3-rapport
Textintervju
Interview with Multiconsult’s CFO Ove B. Haupberg